Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)
China flag China · Delayed Price · Currency is CNY
15.22
+0.01 (0.07%)
May 6, 2026, 3:04 PM CST

SHE:300181 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
718.33680.88804.67931.981,082232.3
Trading Asset Securities
---15110.8365.52
Cash & Short-Term Investments
718.33680.88804.671,0831,093297.82
Cash Growth
-3.06%-15.38%-25.70%-0.91%266.97%-5.39%
Accounts Receivable
1,2561,139783.33532.42510.07337.33
Other Receivables
20.6918.0118.189.0224.4226.77
Receivables
1,2761,157801.52541.44534.5364.1
Inventory
565.72531.81523.75426.52318.83273.59
Prepaid Expenses
--0-7.87-
Other Current Assets
37.7821.2147.515.535.456.16
Total Current Assets
2,5982,3912,1772,0561,960941.67
Property, Plant & Equipment
1,4841,4271,2201,060972.41806.32
Long-Term Investments
492.99411.57254.64179.7392.36650.67
Goodwill
321.37130.32130.32130.32130.32130.32
Other Intangible Assets
280.1682.4275.0871.2763.0464.89
Long-Term Deferred Tax Assets
31.9531.7930.425.525.1415.51
Long-Term Deferred Charges
51.2450.0935.5825.4925.4225.6
Other Long-Term Assets
70.95186.7268.9178.0774.76113.55
Total Assets
5,3314,7123,9923,6273,6432,749
Accounts Payable
517.03425.26482.41433.85468.88296.77
Accrued Expenses
25.3267.6686.5582.2478.3262.33
Short-Term Debt
715.32660.09377.31193.06138.16178.2
Current Portion of Long-Term Debt
3.753.19-10.010.01-
Current Portion of Leases
--3.322.492.834.21
Current Income Taxes Payable
159.41142.8952.5432.6526.5916.46
Current Unearned Revenue
8.765.2614.452.2314.143.06
Other Current Liabilities
245.3134.639.4638.282623.55
Total Current Liabilities
1,6751,3391,056794.83754.94584.58
Long-Term Debt
29.1611.6630.66-10-
Long-Term Leases
18.317.0718.2716.6922.1324.27
Long-Term Unearned Revenue
26.7827.6526.519.919.7622.37
Long-Term Deferred Tax Liabilities
88.217541.0321.6876.24134.1
Total Liabilities
1,8371,4701,173853.09883.07765.31
Common Stock
701.39701.39701.39701.39701.39608.62
Additional Paid-In Capital
1,1511,1421,1351,1351,135340.48
Retained Earnings
1,4571,2571,041849.32676.8525.52
Treasury Stock
-111.88-111.88-203.97---
Comprehensive Income & Other
227.42191.6294.6342.66190.19369.44
Total Common Equity
3,4243,1802,7692,7292,7041,844
Minority Interest
68.9761.2550.5645.256.18139.15
Shareholders' Equity
3,4933,2412,8192,7742,7601,983
Total Liabilities & Equity
5,3314,7123,9923,6273,6432,749
Total Debt
766.53692.01429.56222.25173.13206.67
Net Cash (Debt)
-48.2-11.13375.11860.73919.7791.15
Net Cash Growth
---56.42%-6.42%909.09%-
Net Cash Per Share
-0.07-0.020.541.241.520.15
Filing Date Shares Outstanding
701.31643.39692.47701.39701.39608.62
Total Common Shares Outstanding
701.31643.39686.49701.39701.39608.62
Working Capital
923.181,0521,1211,2621,205357.1
Book Value Per Share
4.884.944.033.893.853.03
Tangible Book Value
2,8232,9672,5632,5272,5101,649
Tangible Book Value Per Share
4.034.613.733.603.582.71
Buildings
--1,014962.71832.63678.11
Machinery
--529.12467.55432.59412.82
Construction In Progress
--161.4361.1478.0640.29
Source: S&P Global Market Intelligence. Standard template. Financial Sources.